Lets highlight some recent trials to prompt discussion. Complications After Transthoracic Needle Biopsy of Pulmonary Nodules: A Population-Level Retrospective Cohort Analysis. pubmed.ncbi.nlm.nih.gov/35738412/
In that study. Among 16,971 patients who underwent TTNB, 25.8% experienced a complication within 3 days of the procedure (pneumothorax 23.3%, hemorrhage 3.6%, and air embolism 0.02%).
Pleural recurrence after transthoracic needle lung biopsy in stage I lung cancer: a systematic review and individual patient-level meta-analysis. TTNB higher risk for or ipsilateral pleural recurrence (HR (sHR), 2.58. pubmed.ncbi.nlm.nih.gov/33723018/
Impact of Preoperative Diagnostic Biopsy Procedure on Spread Through Airspaces (STAS) and Related Outcomes in Resected Stage I NSCLC. There was no elevated risk. doi.org/10.1016/j.ches…
So do we still have equipoise in consenting patients for CT guided biopsy? Or should this procedure go the way of the Abrams needle? Great article by @ostde in @accpchest looking at cost effectiveness doi.org/10.1016/j.ches…